Uni Pharma Co Ltd (6621)

TPEX

Currency in TWD

11.55

+0.10(+0.87%)

Closed·21/09

Fair Value

Unlock Value

Day's Range

11.45

11.60

52 wk Range

10.60

16.00

6621 Income Statement

Featured here, the Income Statement (earnings report) for Uni Pharma Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

105.39

128.11

103.22

93.46

88.44

Total Revenues Growth

aa.aa

-23.98%

+21.56%

-19.43%

-9.46%

-5.36%

Cost Of Revenues

aa.aa

46.06

53.49

52.21

44.75

41.22

Gross Profit

aa.aa

59.33

74.62

51.02

48.71

47.22

Gross Profit Growth

aa.aa

-14.41%

+25.78%

-31.63%

-4.52%

-3.05%

Gross Profit Margin %

aa.aa

56.29%

58.25%

49.42%

52.12%

53.39%

Other Operating Expenses, Total

aa.aa

99.55

95.5

78.32

79.53

91.35

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+10.69%	-4.07%	-17.98%	+1.54%	+14.86%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	33.05	26.32	17.83	16.57	22.83
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	66.5	69.18	60.49	62.96	68.52
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-40.22

-20.88

-27.31

-30.82

-44.13

Operating Income Growth

aa.aa

-95.11%

+48.1%

-30.8%

-12.88%

-43.17%

EBIT Margin %

aa.aa

-38.17%

-16.3%

-26.45%

-32.98%

-49.89%

Net Interest Expenses

aa.aa

1.14

1.22

1.95

1.84

1.98

Net Interest Expenses Growth

aa.aa

-18.19%

+6.85%

+60.44%

-5.69%

+7.72%

Interest Expense, Total

aa.aa

-0.1

-0.04

-0.01

-0.11

-0.1

Interest And Investment Income

aa.aa

1.24

1.26

1.97

1.95

2.08

Other Non Operating Expenses, Total

aa.aa

1.06

1.92

3.54

4.2

1.61

EBT, Excl. Unusual Items

aa.aa

-38.02

-17.74

-21.81

-24.78

-40.53

Gain (Loss) On Sale Of Assets

aa.aa

10.71

-0.04

-0.01

Other Unusual Items, Total

aa.aa

-36.39

EBT, Incl. Unusual Items

aa.aa

-74.41

-7.03

-21.81

-24.82

-40.54

EBT, Incl. Unusual Items Growth

aa.aa

-34.43%

+90.56%

-210.42%

-13.78%

-63.36%

EBT, Incl. Unusual Items Margin

aa.aa

-70.6%

-5.49%

-21.13%

-26.56%

-45.84%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-74.41

-7.03

-21.81

-24.82

-40.54

Minority Interest

aa.aa

0.58

Net Income

aa.aa

-74.41

-6.45

-21.81

-24.82

-40.54

Net Income Growth

aa.aa

-34.43%

+91.34%

-238.4%

-13.78%

-63.36%

Net Income Margin %

aa.aa

-70.6%

-5.03%

-21.13%

-26.56%

-45.84%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-74.41

-6.45

-21.81

-24.82

-40.54

Basic EPS - Continuing Operations

aa.aa

-2.11

-0.18

-0.61

-0.7

-1.14

Basic EPS - Continuing Operations Growth

aa.aa

-34.43%

+91.41%

-238.24%

-13.78%

-63.36%

Diluted EPS - Continuing Operations

aa.aa

-2.11

-0.18

-0.61

-0.7

-1.14

Diluted EPS - Continuing Operations Growth

aa.aa

-34.43%

+91.41%

-238.24%

-13.93%

-63.15%

Basic Weighted Average Shares Outstanding

aa.aa

35.2

35.49

35.5

Diluted Weighted Average Shares Outstanding

aa.aa

35.2

35.49

35.5

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-34.99

-18.8

-24.99

-27.49

-40.89

EBITDA Growth

aa.aa

-130.7%

+46.26%

-32.89%

-10.02%

-48.75%

EBITDA Margin %

aa.aa

-33.2%

-14.68%

-24.21%

-29.42%

-46.24%

EBIT

aa.aa

-40.22

-20.88

-27.31

-30.82

-44.13

* In Millions of TWD (except for per share items)

FAQ

What was Uni Pharma’s revenue at year end?

At the end of the last reported fiscal year, Uni Pharma (6621) recorded total revenue of 88.44 million TWD.

How much revenue did Uni Pharma report in the most recent quarter?

In its most recent quarterly earnings report, Uni Pharma posted revenue of 39.74 million TWD.

What was Uni Pharma’s net income for the year?

For the full year, Uni Pharma reported net income of -40.54 million TWD.

How much net income did Uni Pharma post in the last quarter?

In the most recent quarter, Uni Pharma (6621) posted net income of -23.36 million TWD.

What was Uni Pharma’s gross profit for the year?

Gross profit for the year was reported at 47.22 million TWD.

How much gross profit did Uni Pharma generate last quarter?

Uni Pharma recorded gross profit of 18.81 million TWD in its latest quarterly report.

What was Uni Pharma’s annual operating income?

For the full year, Uni Pharma (6621) reported operating income of -44.13 million TWD.

What was Uni Pharma’s operating income last quarter?

Quarterly operating income was -24.88 million TWD.

What was Uni Pharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -23.31 million TWD.

What was the quarter-over-quarter change in EBITDA for Uni Pharma?

EBITDA changed by -20.74% million TWD compared to the last quarter.

What is Uni Pharma’s most recent gross profit margin?

The latest reported gross profit margin for Uni Pharma (6621) is 47.32% million TWD.

What is Uni Pharma’s most recent net income margin?

Net income margin based on recent financials is -58.78% million TWD.

What is Uni Pharma’s most recent EBIT margin?

Uni Pharma reported an EBIT margin of -62.61% million TWD based on current figures.

How did Uni Pharma’s revenue change compared to the previous quarter?

Revenue changed by -9.93% million TWD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Uni Pharma?

In the latest quarter, gross profit changed by -21.13% million TWD from the previous quarter.

PSEi Composite

5,843.79

-12.12

-0.21%

Nikkei 225

65,018.95

+882.70

+1.38%

Shanghai

3,949.91

+38.04

+0.97%

US 500

7,771.30

+6.5

+0.08%

US Tech 100

30,515.00

+32.7

+0.11%

DAX

25,575.01

+270.95

+1.07%

Dollar Index

100.15

+0.220

+0.22%

Market Movers

Name	Last	Chg. %	Vol.
International Container	898.000	-0.77%	964.29K
Ayala	533.00	+5.13%	1.56M
SM Investments	513.00	+1.99%	1.01M
Metropolitan Bank	61.60	+1.73%	4.30M
Ayala Land	15.180	+1.20%	14.63M
SM Prime	16.500	0.00%	12.74M
BDO Unibank	113.30	+0.27%	1.66M

Name	Last	Chg. %	Vol.
Seafront Resources	2.600	+30.00%	23.00K
Cirtek Holdings Philippines Prf	7.50	+22.35%	900.00
Vantage Equities	1.4400	+12.50%	9.91M
ACE Enexor	3.900	+11.43%	159.00K
Vivant	20.600	+10.75%	600.00
Alliance Foods	0.430	+10.26%	20.00K
PXP Energy	3.340	+8.79%	1.38M

Name	Last	Chg. %	Vol.
LBC Express	7.030	-12.13%	100.00
LMG Chemicals	0.375	-10.71%	100.00K
Roxas	2.990	-9.39%	625.00K
Citystate Savings Bank	13.000	-8.96%	500.00
NiHAO Mineral	0.530	-8.62%	49.00K
Dizon Copper Silver	4.3000	-8.51%	3.00K
Supercity Realty Dev	29.65	-7.78%	12.30K

Trending Stocks

Name	Last	Chg. %	Vol.
Philex Mining	13.200	+0.76%	9.11M
Metropolitan Bank	61.60	+1.73%	4.30M
BDO Unibank	113.30	+0.27%	1.66M
Ayala	533.00	+5.13%	1.56M
DigiPlus Interactive	8.180	-6.41%	7.29M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaa A	19.040	+56.45%	29.788
Aaaaa Aa	207.000	+52.03%	314.702
Aa Aaaaaaaaa	2.110	+51.31%	3.193
Aaaaaaaaaaaaaa	37.300	+50.52%	56.144
A Aaaaaaaaa Aaa	22.00	+38.59%	30.49
Aaa Aaaaaa Aaa A A	90.650	+36.53%	123.764
Aaaaaa Aaa Aa Aaa	2.020	+36.51%	2.758

Name	Last	Upside	Fair Value
A Aaaaa A	19.040	+56.45%	29.788
Aaaaa Aa	207.000	+52.03%	314.702
Aa Aaaaaaaaa	2.110	+51.31%	3.193
Aaaaaaaaaaaaaa	37.300	+50.52%	56.144
A Aaaaaaaaa Aaa	22.00	+38.59%	30.49
Aaa Aaaaaa Aaa A A	90.650	+36.53%	123.764
Aaaaaa Aaa Aa Aaa	2.020	+36.51%	2.758

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Uni Pharma Co Ltd (6621)

6621 Income Statement

FAQ

What was Uni Pharma’s revenue at year end?

How much revenue did Uni Pharma report in the most recent quarter?

What was Uni Pharma’s net income for the year?

How much net income did Uni Pharma post in the last quarter?

What was Uni Pharma’s gross profit for the year?

How much gross profit did Uni Pharma generate last quarter?

What was Uni Pharma’s annual operating income?

What was Uni Pharma’s operating income last quarter?

What was Uni Pharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Uni Pharma?

What is Uni Pharma’s most recent gross profit margin?

What is Uni Pharma’s most recent net income margin?

What is Uni Pharma’s most recent EBIT margin?

How did Uni Pharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Uni Pharma?

Trending Stocks